Towards intelligent supply networks: AI‑enabled simulation in the evolution of digital twins for autologous cell therapy manufacturing
Cell and Gene Therapy Insights · 01.06.2026 · 12 (4) · 482–490
DOI: 10.18609/cgti.2026.052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 01.06.2026. Verfasst von Kan Wang und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Autologous cell therapy (AuCT) supply chains are complex in ways that differ fundamentally from those of modern industrial products such as automobiles, aerospace, or cell phones. Industrial supply chains manage thousands of parts across multi‑tiered networks, whereas AuCT supply chains are complex because of their tightly coupled production and logistics. Each AuCT batch is linked to a single patient, requiring chain‑of‑identity, chain‑of‑custody, and chain of control. Moreover, each AuCT batch must align clinical appointments with manufacturing slots and logistic schedules to ensure reliable operation. In practice, courier delays, quality release holds, contamination events, and manufacturing capacity conflicts can propagate across stages, extending vein‑to‑vein time and hence reducing patient benefit. In recent years, simulation models have emerged as a tool for AuCT supply chains to evaluate patient service levels, throughput, and cost. However, researchers still need to define ‘what‑if’ scenarios, configure supply chain parameters, and interpret results to run experiments on simulation models, rendering this approach difficult to scale and reproduce. An AI‑enabled supply chain simulation framework is proposed to formalize simulation‑based experimentation through an agentic orchestration layer. The framework simultaneously monitors performance degradation, generates causal hypotheses, conducts targeted comparative experiments, and ranks resilience priorities. Rather than treating the digital model merely as a stress‑testing tool, the framework structures and automates the reasoning process surrounding experimentation. This opens new academic opportunities for studying AuCT supply chains. The proposed framework operates as an AI‑enabled supply chain simulation model and is positioned as a foundational step toward the ultimate realization of a supply chain digital twin. While it does not incorporate real‑time data integration or closed‑loop control, it establishes a structured, hypothesis‑driven approach for scalable and reproducible experimentation in AuCT supply chains.
Zitieren
APA
Wang, K., Li, Z., White, C., & Wang, B. (2026). Towards intelligent supply networks: AI‑enabled simulation in the evolution of digital twins for autologous cell therapy manufacturing. Cell and Gene Therapy Insights, 12(4), 482–490. https://doi.org/10.18609/cgti.2026.052
Vancouver
Wang K, Li Z, White C, Wang B. Towards intelligent supply networks: AI‑enabled simulation in the evolution of digital twins for autologous cell therapy manufacturing. Cell and Gene Therapy Insights. 2026;12(4):482–490. doi:10.18609/cgti.2026.052
BibTeX
@article{Wang2026,
author = {Wang, Kan and Li, Zhaowei and White, Chip and Wang, Ben},
title = {Towards intelligent supply networks: AI‑enabled simulation in the evolution of digital twins for autologous cell therapy manufacturing},
journal = {Cell and Gene Therapy Insights},
year = {2026},
volume = {12},
number = {4},
pages = {482–490},
doi = {10.18609/cgti.2026.052}
}
EUVIMED